Cambridge Investment Research Advisors
RKDA icon

Cambridge Investment Research Advisors’s Arcadia Biosciences RKDA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-275
Closed -$34K – 2397
2019
Q2 		$34K Buy
+275
New +$58.5K ﹤0.01% 2167

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cambridge Investment Research Advisors's RKDA Position: Q3 2019 in Review

Cambridge Investment Research Advisors sold out of Arcadia Biosciences (RKDA) in Q3 2019, closing a stake of 275 shares — an estimated $34K sold.

Cambridge Investment Research Advisors first reported a position in RKDA in Q2 2019 and held it in 1 quarter. The position peaked at $34K in Q2 2019. 18 funds tracked by Wall St. Rank hold RKDA as of Q3 2019.

  • Cambridge Investment Research Advisors reported no remaining Arcadia Biosciences position as of Q3 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 275 Arcadia Biosciences shares in Q3 2019, an estimated $34K.
  • Cambridge Investment Research Advisors first reported a position in Arcadia Biosciences in Q2 2019 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Arcadia Biosciences position peaked at $34K in Q2 2019.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.